These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29412203)

  • 1. The effect of surface charge on oral absorption of polymeric nanoparticles.
    Du XJ; Wang JL; Iqbal S; Li HJ; Cao ZT; Wang YC; Du JZ; Wang J
    Biomater Sci; 2018 Feb; 6(3):642-650. PubMed ID: 29412203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research on the fate of polymeric nanoparticles in the process of the intestinal absorption based on model nanoparticles with various characteristics: size, surface charge and pro-hydrophobics.
    Guo S; Liang Y; Liu L; Yin M; Wang A; Sun K; Li Y; Shi Y
    J Nanobiotechnology; 2021 Jan; 19(1):32. PubMed ID: 33499885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functionalized PLA-PEG nanoparticles targeting intestinal transporter PepT1 for oral delivery of acyclovir.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Baumy P; Cisternino S; Péan JM; Declèves X
    Int J Pharm; 2017 Aug; 529(1-2):357-370. PubMed ID: 28705621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of PLA-PEG nanoparticles manufacturing process on intestinal transporter PepT1 targeting and oxytocin transport.
    Gourdon B; Chemin C; Moreau A; Arnauld T; Delbos JM; Péan JM; Declèves X
    Eur J Pharm Biopharm; 2018 Aug; 129():122-133. PubMed ID: 29803721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
    Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OCTN2-targeted nanoparticles for oral delivery of paclitaxel: differential impact of the polyethylene glycol linker size on drug delivery
    Kou L; Sun R; Xiao S; Cui X; Sun J; Ganapathy V; Yao Q; Chen R
    Drug Deliv; 2020 Dec; 27(1):170-179. PubMed ID: 31913724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ascorbyl palmitate/DSPE-PEG nanocarriers for oral iron delivery: preparation, characterisation and in vitro evaluation.
    Zariwala MG; Farnaud S; Merchant Z; Somavarapu S; Renshaw D
    Colloids Surf B Biointerfaces; 2014 Mar; 115():86-92. PubMed ID: 24333557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
    Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
    Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
    Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
    J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan.
    Sheng Y; Liu C; Yuan Y; Tao X; Yang F; Shan X; Zhou H; Xu F
    Biomaterials; 2009 Apr; 30(12):2340-8. PubMed ID: 19150737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionically fixed polymeric nanoparticles as a novel drug carrier.
    Lee SW; Chang DH; Shim MS; Kim BO; Kim SO; Seo MH
    Pharm Res; 2007 Aug; 24(8):1508-16. PubMed ID: 17380262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical determinant of intestinal permeability and oral bioavailability of pegylated all trans-retinoic acid prodrug-based nanomicelles: Chain length of poly (ethylene glycol) corona.
    Li Z; Han X; Zhai Y; Lian H; Zhang D; Zhang W; Wang Y; He Z; Liu Z; Sun J
    Colloids Surf B Biointerfaces; 2015 Jun; 130():133-40. PubMed ID: 25907597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surface charge, particle size, and modification by polyethylene glycol of liposomes on their association with Caco-2 cells across an unstirred water layer.
    Kono Y; Iwasaki A; Fujita T
    Pharmazie; 2018 Jan; 73(1):3-8. PubMed ID: 29441943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density.
    Essa S; Rabanel JM; Hildgen P
    Int J Pharm; 2011 Jun; 411(1-2):178-87. PubMed ID: 21458551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
    Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of PEG-grafted-PLA nanoparticles as oral permeability enhancer for P-gp substrate drug model Famotidine.
    Mokhtar M; Gosselin P; Lacasse F; Hildgen P
    J Microencapsul; 2017 Feb; 34(1):91-103. PubMed ID: 28151040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier.
    Beloqui A; des Rieux A; Préat V
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):242-255. PubMed ID: 27117710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.